Literature DB >> 27894919

Resveratrol attenuates MPP+-induced mitochondrial dysfunction and cell apoptosis via AKT/GSK-3β pathway in SN4741 cells.

Weijun Zeng1, Wei Zhang2, Fangfang Lu1, Li Gao1, Guodong Gao3.   

Abstract

Oxidative stress and mitochondrial dysfunction play crucial role in the dopaminergic neurons death, which is the pathological feature of Parkinson's disease (PD). Resveratrol (Res), a polyphenol derived from grapes and blueberries, has been reported to reduce oxidative stress injury and to restore mitochondrial function. In this study, we aimed to explore the underlying molecular mechanism of the beneficial effects of Res against MPP+- induced mitochondrial dysfunction and cell apoptosis in SN4741 cells. The data showed that Res significantly alleviated MPP+- induce cytotoxicity and restored MPP+- induced mitochondrial dysfunction in SN4741 cells. Moreover, Res rescued MPP+- induced a decline on the level of p-AKT, p-GSK-3βand the ratio of Bcl-2/Bax, and an elevation on the expression of Bax and caspase-3, 9. However, inhibition GSK-3β activity clearly abolished the protective effects of Res. Taken together, these results suggest that Res attenuates MPP+- induced mitochondrial dysfunction and cell apoptosis, and these protections may be achieved through AKT/GSK-3β pathway. These also indicate that Res could be a promising therapeutic agent for PD.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  GSK-3β; Mitochondria; Neuronal apoptosis; Parkinson's disease; Resveratrol

Mesh:

Substances:

Year:  2016        PMID: 27894919     DOI: 10.1016/j.neulet.2016.11.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.

Authors:  Zheng Liu; Wei Cai; Ming Lang; Ruizuo Yan; Zhenshen Li; Gaoxiao Zhang; Pei Yu; Yuqiang Wang; Yewei Sun; Zaijun Zhang
Journal:  J Mol Neurosci       Date:  2017-01-31       Impact factor: 3.444

Review 2.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

3.  Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.

Authors:  Suresh Palle; Prasad Neerati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

4.  Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury.

Authors:  Peng Wang; Lizhu Jiang; Nian Zhou; Hao Zhou; Huzhe Liu; Wenrui Zhao; Hanxiang Zhang; Xiang Zhang; Zhenming Hu
Journal:  Oncotarget       Date:  2018-01-03

5.  GSK-3β Inhibitor Alsterpaullone Attenuates MPP+-Induced Cell Damage in a c-Myc-Dependent Manner in SH-SY5Y Cells.

Authors:  Jiancai Wang; Yuqian Li; Li Gao; Fengqi Yan; Guodong Gao; Lihong Li
Journal:  Front Cell Neurosci       Date:  2018-08-30       Impact factor: 5.505

Review 6.  Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.

Authors:  Stephanie Andrade; Maria João Ramalho; Maria do Carmo Pereira; Joana A Loureiro
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

7.  Da-Bu-Yin-Wan and Qian-Zheng-San Ameliorate Mitochondrial Dynamics in the Parkinson's Disease Cell Model Induced by MPP.

Authors:  Cong Gai; Wan-Di Feng; Tian-Yao Qiang; Hao-Jie Ma; Yuan Chai; Shu-Jing Zhang; Zhen-Yu Guo; Jing-Hong Hu; Hong-Mei Sun
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

8.  Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy.

Authors:  Yingfeng Shi; Min Tao; Xiaoyan Ma; Yan Hu; Guansen Huang; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Cell Death Dis       Date:  2020-06-17       Impact factor: 8.469

Review 9.  The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders.

Authors:  Francesca Oppedisano; Jessica Maiuolo; Micaela Gliozzi; Vincenzo Musolino; Cristina Carresi; Saverio Nucera; Miriam Scicchitano; Federica Scarano; Francesca Bosco; Roberta Macrì; Stefano Ruga; Maria Caterina Zito; Ernesto Palma; Carolina Muscoli; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

Review 10.  Dosis Facit Sanitatem-Concentration-Dependent Effects of Resveratrol on Mitochondria.

Authors:  Corina T Madreiter-Sokolowski; Armin A Sokolowski; Wolfgang F Graier
Journal:  Nutrients       Date:  2017-10-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.